Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing Divarasib to Sotorasib or Adagrasib in previously treated KRAS G12C-positive advanced or metastatic non-small cell lung cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Adagrasib (adagrasib)
• Divarasib
• sotorasib (sotorasib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING